Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Raising the bar in maternofetal hematology: Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds

Daniel Wang, Manraj Sra, Satoko Ito, Adam Cuker, George Goshua

Blood (2025) 146 (Supplement 1): 598.

https://doi.org/10.1182/blood-2025-598

Published: 2025

Journal Articles

Early discharge program cost savings for patients with newly diagnosed acute myeloid leukemia after intensive induction chemotherapy

Cameron Hunter, Karthik Chetlapalli, Satoko Ito, Jan Philipp Bewersdorf, Prajwal Boddu, Sabrina Browning, Stephanie Halene, Terri Parker, Scott Huntington, Shalin Kothari, Lourdes Mendez, Natalia Neparidze, Tarsheen Sethi, Maximilian Stahl, Nikolai Podoltsev, Amer Zeidan, Rory Shallis, George Goshua

Blood (2025) 146 (Supplement 1): 6208.

https://doi.org/10.1182/blood-2025-6208

Published: 2025

Journal Articles

primary prophylaxis with direct oral anticoagulants (DOACs) for transwomen taking estrogen is not cost-effective

Jorge Ruiz Lopez, Sarah Peterson, Satoko Ito, Lorena Alarcon-Casas Wright, Bradley Anawalt, David Garcia, George Goshua

Blood (2025) 146 (Supplement 1): 6161.

https://doi.org/10.1182/blood-2025-6161

Published: 2025

Journal Articles

Cost savings across bone marrow testing strategies in persons with suspected monoclonal gammopathy of undetermined significance

Manraj Sra, Karthik Chetlapalli, Satoko Ito, Ding Quan Ng, Kishan Patel, Yuxin Liu, George Goshua

Blood (2025) 146 (Supplement 1): 4409.

https://doi.org/10.1182/blood-2025-4409

Published: 2025

Journal Articles

Cost-effectiveness of heparin-induced thrombocytopenia (HIT) diagnostic strategies: Rapid PF4/heparin versus ELISA-based antibody testing strategies in the care of hospitalized people with suspected HIT

Cecily Allen, Satoko Ito, Adam Cuker, George Goshua

Blood (2025) 146 (Supplement 1): 1072.

https://doi.org/10.1182/blood-2025-1072

Published: 2025

Journal Articles

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Satoko Ito, Karthik Chetlapalli, Daniel Wang, Kunal C. Potnis, Rhys Richmond, Harlan M. Krumholz, Alfred I. Lee, Adam Cuker, George Goshua

Blood (2025) 145 (1): 127–140.

https://doi.org/10.1182/blood.2024025176

Published: 2025

Includes: Supplemental data

Journal Articles

Cost-Effectiveness of Eltrombopag Plus Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone in Adults with Severe Aplastic Anemia in the United States

Kunal C Potnis, Satoko Ito, Kishan Patel, Rory M. Shallis, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Scott F Huntington, Maximilian Stahl, Amer M. Zeidan, Jan Philipp Bewersdorf, George Goshua

Blood (2024) 144 (Supplement 1): 3644.

https://doi.org/10.1182/blood-2024-204312

Published: 2024

Journal Articles

Deciding between Multiple Curative Options in Sickle Cell Disease: Cost-Effectiveness of Non-Myeloablative/Reduced Intensity Conditioning Haploidentical Allo-HSCT Vs Gene Therapy Vs Standard of Care in Adult Patients with Sickle Cell Disease

Karthik Chetlapalli, Ayesha Butt, Satoko Ito, Daniel Wang, Cecelia Calhoun, Lakshmanan Krishnamurti, Ankur Pandya, George Goshua

Blood (2024) 144 (Supplement 1): 601.

https://doi.org/10.1182/blood-2024-203234

Published: 2024

Journal Articles

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Samira Glaeser-Khan, Rhys Richmond, Satoko Ito, Robert D Bona, Harlan M. Krumholz, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 157.

https://doi.org/10.1182/blood-2024-203690

Published: 2024

Journal Articles

Cost-Effectiveness of Universal Duffy Testing at 9-12 Months: An Effort Towards Equity in Interpreting Absolute Neutrophil Counts (ANC)

Lauren E. Merz, Satoko Ito, Kelly J. Walkovich, Maureen Achebe, Nathalie Van Havre, Patricia Frustace, George Goshua

Blood (2024) 144 (Supplement 1): 162.

https://doi.org/10.1182/blood-2024-202605

Published: 2024

Journal Articles

Cost-Effectiveness of Allogeneic Hematopoietic Stem Cell Transplantation Versus Consolidation Chemotherapy for Patients with Intermediate Risk Acute Myeloid Leukemia

Abdulrahman Alhajahjeh, Kishan Patel, Rory M. Shallis, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Scott F Huntington, Maximilian Stahl, Amer M. Zeidan, George Goshua, Jan Philipp Bewersdorf

Blood (2024) 144 (Supplement 1): 788.

https://doi.org/10.1182/blood-2024-201535

Published: 2024

Journal Articles

Cost-Effectiveness of Oral Versus Intravenous First-Line Treatment of Severe Iron Deficiency Anemia in Women with Heavy Menstrual Bleeding

Daniel Wang, Daniel Y Wang, Samira Glaeser-Khan, Ranya Moshashaian Asl, Karthik Chetlapalli, Satoko Ito, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 281.

https://doi.org/10.1182/blood-2024-198803

Published: 2024

Journal Articles

Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age

Daniel Wang, Samira Glaeser-Khan, Daniel Y Wang, Ranya Moshashaian Asl, Karthik Chetlapalli, Satoko Ito, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 277.

https://doi.org/10.1182/blood-2024-203654

Published: 2024

Journal Articles

Identifying Patients with Erythrocytosis Not Requiring JAK2 Testing: External Validation and Decision Analysis of the Jakpot Prediction Rule

Barbara D Lam, Satoko Ito, Justine Ryu, Kevin O'Sullivan, Kunal C Potnis, Roosevelt Lu, Aram Bidikian, Jason A Freed, Jennifer La, George Goshua

Blood (2024) 144 (Supplement 1): 3669.

https://doi.org/10.1182/blood-2024-198033

Published: 2024

Journal Articles

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D. Bona, Adam Cuker, George Goshua

Blood (2024) 143 (22): 2332–2335.

https://doi.org/10.1182/blood.2024024209

Published: 2024

Includes: Supplemental data

Journal Articles

Consecutive Inpatient Hematology Consultation Service Utilization across 11 Years in the Medical Intensive Care Unit

Cecily Allen, Michael Streiff, Rakhi P P. Naik, Melissa Knauert, George Goshua

Blood (2023) 142 (Supplement 1): 2323.

https://doi.org/10.1182/blood-2023-184891

Published: 2023

Journal Articles

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Satoko Ito, Daniel Wang, Adriana Purcell, Karthik Chetlapalli, Alfred I Lee, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 2316.

https://doi.org/10.1182/blood-2023-187270

Published: 2023

Journal Articles

Second-Line Therapy Sequencing in Primary Warm Autoimmune Hemolytic Anemia: Splenectomy-Rituximab Versus Rituximab-Splenectomy

Christina Waldron, Satoko Ito, Daniel Wang, Giri Viswanathan, Ayesha Butt, George Goshua

Blood (2023) 142 (Supplement 1): 2317.

https://doi.org/10.1182/blood-2023-189957

Published: 2023

Journal Articles

Proteomic Profiling of Different Antiphospholipid Antibody-Positive Phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry

Blood (2023) 142 (Supplement 1): 2575.

https://doi.org/10.1182/blood-2023-185232

Published: 2023

Journal Articles

Cost-Effectiveness of Rapid Hemosil Versus in-House and Send-out ADAMTS13 Activity Testing in the Care of Patients with Immune Thrombotic Thrombocytopenic Purpura

Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 368.

https://doi.org/10.1182/blood-2023-184927

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Raising the bar in maternofetal hematology: Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds

Early discharge program cost savings for patients with newly diagnosed acute myeloid leukemia after intensive induction chemotherapy

primary prophylaxis with direct oral anticoagulants (DOACs) for transwomen taking estrogen is not cost-effective

Cost savings across bone marrow testing strategies in persons with suspected monoclonal gammopathy of undetermined significance

Cost-effectiveness of heparin-induced thrombocytopenia (HIT) diagnostic strategies: Rapid PF4/heparin versus ELISA-based antibody testing strategies in the care of hospitalized people with suspected HIT

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Cost-Effectiveness of Eltrombopag Plus Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone in Adults with Severe Aplastic Anemia in the United States

Deciding between Multiple Curative Options in Sickle Cell Disease: Cost-Effectiveness of Non-Myeloablative/Reduced Intensity Conditioning Haploidentical Allo-HSCT Vs Gene Therapy Vs Standard of Care in Adult Patients with Sickle Cell Disease

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Cost-Effectiveness of Universal Duffy Testing at 9-12 Months: An Effort Towards Equity in Interpreting Absolute Neutrophil Counts (ANC)

Cost-Effectiveness of Allogeneic Hematopoietic Stem Cell Transplantation Versus Consolidation Chemotherapy for Patients with Intermediate Risk Acute Myeloid Leukemia

Cost-Effectiveness of Oral Versus Intravenous First-Line Treatment of Severe Iron Deficiency Anemia in Women with Heavy Menstrual Bleeding

Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age

Identifying Patients with Erythrocytosis Not Requiring JAK2 Testing: External Validation and Decision Analysis of the Jakpot Prediction Rule

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Consecutive Inpatient Hematology Consultation Service Utilization across 11 Years in the Medical Intensive Care Unit

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Second-Line Therapy Sequencing in Primary Warm Autoimmune Hemolytic Anemia: Splenectomy-Rituximab Versus Rituximab-Splenectomy

Proteomic Profiling of Different Antiphospholipid Antibody-Positive Phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry

Cost-Effectiveness of Rapid Hemosil Versus in-House and Send-out ADAMTS13 Activity Testing in the Care of Patients with Immune Thrombotic Thrombocytopenic Purpura

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only